Posted inStock
Cytokinetics stock rises on Sanofi’s rights acquisition
Investing.com — Shares of Cytokinetics (NASDAQ:CYTK), Incorporated (NASDAQ:CYTK) climbed 4.8% after the company announced that Sanofi (NASDAQ:SNY) will acquire exclusive rights to develop and commercialize aficamten in Greater China, a…